Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
A Controversial Alzheimer’s Drug Has Gone Down in Flames
Cassava Sciences' simufilam failed a Phase III trial for Alzheimer's disease, likely marking the end of a drug surrounded by allegations of poorly done and fraudulent research.
Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.
Controversial Alzheimer's drug trial halted
The trial, which involved patients with mild-to-moderate Alzheimer's disease, failed to show significant improvement in cognition and daily functioning compared to a placebo after 52 weeks, according to a Nov.
Hosted on MSN
14h
Alzheimer's Trials Fail; Blood Test Predicts Tau; Neuroscience Moves to Bluesky
Investigational simufilam failed to reduce cognitive or functional decline in Alzheimer's disease patients in the ReThink-ALZ ...
yourlifechoices.com.au
34m
Novel therapy could delay Alzheimer’s by up to 15 years, study finds
What if fighting the onset of dementia was as simple as a few sniffs? Researchers at Texas A&M have discovered a new therapy ...
KTNV Las Vegas
13h
National Alzheimer’s Awareness Month highlights financial risks for seniors
LAS VEGAS (KTNV) — November is National
Alzheimer
’s Awareness Month, and this year, experts are shining a light on a ...
1d
on MSN
Cassava shares sink on plans to stop Alzheimer's drug studies
(Reuters) -Cassava Sciences said it will stop all trials of its Alzheimer's disease drug after it failed a late-stage study, ...
18h
Alzheimer's awareness: 10 early warning signs, 10 healthy habits
Stay alert with list of early signs and symptoms of dementia that disrupts daily life and may be a symptom of Alzheimer’s or ...
20h
Alzheimer’s disease: toxic protein is turned bad by immune enzyme, mouse study shows
Tau behaves abnormally in the brain in people with Alzheimer’s disease. This latest study points to a reason why.
Psychology Today
23h
The Relationship Between Music and Alzheimer’s Disease
Alzheimer’s is the most common type of dementia. Music therapy can improve mood and cognitive performance in Alzheimer’s ...
The Times and Democrat
1h
Assessment shows Alzheimer’s care needs - Orangeburg County has ‘staggering’ level of disease
An Orangeburg County assessment identified several actions that could be taken to address
Alzheimer
’s disease in the ...
McKnight's Senior Living
7h
California notes progress in Alzheimer’s support plans, looks toward dementia-capable continuum of care
Guided by the Alzheimer's Disease Prevention and Preparedness Task Force, California has taken “significant” action and made ...
WOLF Wilkes-Barre-Scranton on MSN
9h
Alliance for Aging Research advocates for Medicare coverage of early Alzheimer's drugs
November is National Alzheimer’s Awareness Month.The Alliance for Aging Research is using this month to raise awareness about ...
BioSpace
3h
BridgeBio’s ATTR-CM Approval, Cassava’s Alzheimer’s Failure, Trump’s Cabinet Picks, More
BridgeBio’s Attruby wins approval for transthyretin amyloid cardiomyopathy while the FDA accepts Alnylam’s application for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Cassava
Alector
simufilam
Feedback